Hekmat Zarzour

Hekmat Zarzour

Auto-generated profile, based on publicly available information

Hekmat Zarzour

Department of Neurological Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2020 in Neurosurgery
Verified
Journal Article
Closed access
ASAhmad Sweid
Ahmad Sweid
BHBatoul Hammoud
Batoul Hammoud
JWJoshua H. Weinberg
Joshua H. Weinberg
MOMazen Oneissi
Mazen Oneissi
EREytan Raz
Eytan Raz
PJPascal Jabbour
Pascal Jabbour

1 December 2018 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
ASA. Sweid
A. Sweid
EAElias Atallah
Elias Atallah
NHN. Herial
N. Herial
HSH. Saad
H. Saad
NMNikolaos Mouchtouris
Nikolaos Mouchtouris
PJPascal Jabbour
Pascal Jabbour

1 December 2022 in Journal of Neurosurgery
Verified
Journal Article
Closed access
PDF file
KNKareem El Naamani
Kareem El Naamani
CCChing-Jen Chen
Ching-Jen Chen
RARawad Abbas
Rawad Abbas
ASAhmad Sweid
Ahmad Sweid
GSGeorgios Sioutas
Georgios Sioutas
PJPascal Jabbour
Pascal Jabbour
OBJECTIVE: Stent-assisted coil (SAC) embolization has been the mainstay endovascular treatment for bifurcation aneurysms. The recent introduction of the Woven EndoBridge (WEB) device has presented an alternative endovascular treatment modality for these aneurysms. Direct comparisons of outcomes between these two modalities are limited in the literature. Here, the authors compared the outcomes of bifurcation aneurysms treated with SAC and WEB devices. METHODS: This retrospective single-center study comprised 148 bifurcation aneurysms that were treated endovascularly with SAC or WEB devices between 2011 and 2019. The primary outcome was complete occlusion of the aneurysm at 6 months on catheter angiography. RESULTS: The SAC and WEB cohorts comprised 85 and 63 aneurysms, respectively. The baseline characteristics were well balanced after inverse probability weight (IPW) adjustment, except for smoking status. The 6-month complete occlusion rate was higher in the WEB cohort than the SAC cohort (67.4% vs 40.6%; unadjusted OR [95% CI] 3.014 [1.385–6.563], p = 0.005). However, this difference in complete occlusion rates did not remain significant after IPW adjustment and multiple imputations. The neck remnant rate was lower in the WEB cohort than the SAC cohort (20% vs 50%; OR [95% CI] 0.250 [0.107–0.584], p = 0.001), and this difference remained significant after IPW adjustment (OR [95% CI] 0.304 [0.116–0.795], p = 0.015) and multiple imputations. CONCLUSIONS: Use of SAC and WEB demonstrated comparable 6-month complete occlusion rates for bifurcation aneurysms. WEB appeared to be associated with a lower rate of neck remnant at 6 and 12 months compared with SAC. WEB was also associated with fewer complications and decreased retreatment rates compared with SAC.

26 May 2020 in Neurosurgery
Verified
Journal Article
Closed access
ASAhmad Sweid
Ahmad Sweid
NHNabeel Herial
Nabeel Herial
KSKalyan Sajja
Kalyan Sajja
NCNohra Chalouhi
Nohra Chalouhi
LVLohit Velagapudi
Lohit Velagapudi
MGM Reid Gooch
M Reid Gooch
BACKGROUND: The Neuroform Atlas stent™ (by Stryker, Fremont, California) represents the most recent widely available upgrade to intracranial stenting, providing a laser cut open cell stent with a diameter of 3.0 to 4.5 mm that is delivered through an 0.017-inch microcatheter. OBJECTIVE: To report our initial multicenter experience of the safety, efficacy, and feasibility of the Atlas stent used for treating aneurysms, as well as one case of intracranial stenosis and one carotid artery dissection as well as other pathologies. METHODS: A retrospective multicenter study of subjects treated with Atlas stent during the period 2018 to 2019. RESULTS: The total number of patients included in our analysis was 71 patients. The stent was utilized to treat 69 aneurysm cases. Of the aneurysms, 36% presented with acute rupture and 56% of the ruptured aneurysms were high grade. Mean aneurysm dimension was 7 mm with an average neck width of 4.1 mm. Around 30% had received prior treatment. Telescoping or Y-stent was used in 16% of cases. We did not observe any symptomatic major complications in our series. Asymptomatic major complications were seen in 7 patients (10.1%); technical complications occurred in 4.3%. Immediate modified Raymond-Roy-occlusion-outcome class I/II was observed in 87%, and this increased to 97.7% at latest follow-up, which was at 4 mo; 91.8% of patients achieved favorable clinical outcome, and mortality rate was 1.4%. CONCLUSION: Our series demonstrates the safety, feasibility, and efficacy of the Atlas stent. The low complication rate and the high obliteration rate managing complex aneurysms, even in an acute ruptured setting, are notable.

1 March 2021 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
JWJoshua H. Weinberg
Joshua H. Weinberg
ASAhmad Sweid
Ahmad Sweid
AHAmeer E. Hassan
Ameer E. Hassan
WTWondwossen Tekle
Wondwossen Tekle
KSKalyan Sajja
Kalyan Sajja
PJPascal Jabbour
Pascal Jabbour

25 May 2020 in Operative Neurosurgery
Verified
Journal Article
Closed access
PDF file
JWJoshua H. Weinberg
Joshua H. Weinberg
ASAhmad Sweid
Ahmad Sweid
OKOmaditya Khanna
Omaditya Khanna
NMNikolaos Mouchtouris
Nikolaos Mouchtouris
AAAshlee Asada
Ashlee Asada
PJPascal Jabbour
Pascal Jabbour
BACKGROUND: Distal transradial catheterization in the anatomic snuffbox is an alternate route of access that has started to gain consideration for neuroendovascular procedures. OBJECTIVE: To assess the feasibility and outcomes and present our institution's experience in performing neuroendovascular procedures via distal transradial access (dTRA). METHODS: We conducted a retrospective analysis and identified 120 patients who underwent consecutive neuroendovascular procedures via dTRA in the anatomic snuffbox. Data collection was performed on indication for procedure, sheath size, number of vessels selectively catheterized, fluoroscopy time, procedure duration, radiation exposure, conversion to femoral approach, access site complication, and procedure success. RESULTS: Of 120 patients with an average age of 54.7 yr ± 14.7, 73 (60.8%) underwent diagnostic angiograms, 38 (31.7%) underwent follow-up angiograms, and 9 (7.5%) underwent therapeutic procedures. The overall mean number of vessels catheterized was 2.5 ± 0.1 per procedure, the mean procedure time was 68.3 min ± 43.4, the mean fluoroscopy time was 10.8 min ± 7.6, the mean contrast dose was 70.6 mL ± 39.1, and the mean radiation exposure was 27 672.2 mGycm2 ± 42 728.4. Successfully completed therapeutic procedures included aneurysm 1 (0.8%), arteriovenous malformation (AVM)/arteriovenous fistula/carotid cavernous fistula 7 (5.8%), and 1 (0.8%) other treatment. Three patients (2.5%) required adjunct transfemoral endovenous access for AVM embolization. Two minor complications (1.67%) were a local wrist hematoma and a radial artery vasospasm without any sequelae. CONCLUSION: Distal radial artery catheterization in the anatomic snuffbox is a safe and effective access site to perform neuroendovascular procedures. Complications and conversion rate are low making it a safe alternative.